<DOC>
	<DOCNO>NCT01217905</DOCNO>
	<brief_summary>This study Japanese healthy volunteer determine safety tolerability compound AZD7687 . It also assess body handle drug respond drug follow single dose follow multiple dose 7 day .</brief_summary>
	<brief_title>Japanese Single Multiple Ascending Dose , Safety , Tolerability , Pharmacokinetic ( PK ) &amp; Pharmacodynamic ( PD ) Study AZD7687</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Suitable vein cannulation repeat venipuncture Have body mass index ( BMI ) 19 35 kg/m2 weigh least 50 kg 90 kg Male subject willing use barrier contraception ie , condom spermicide , first day dose 3 month last dose investigational product History clinically significant disease disorder , opinion Investigator , may either put subject risk participation study , influence result subject 's ability participate study . History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug Any clinically significant illness , medical/surgical procedure trauma within 4 week first administration investigational product</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>obesity</keyword>
	<keyword>Japanese healthy volunteer</keyword>
	<keyword>AZD7687</keyword>
</DOC>